Argent Biopharma (AU:RGT) has released an update.
Argent Biopharma Limited has announced its application for quotation of 2.5 million ordinary fully paid securities on the ASX under the code RGT. The announcement, dated July 17, 2024, indicates the company’s expansion in the stock market. Investors may watch this development closely as it signifies Argent’s growth trajectory.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
